622
Views
51
CrossRef citations to date
0
Altmetric
Research Article

Diagnosing invasive fungal disease in critically ill patients

, MD, MPH, , MD, , BA, , MD, , MD & , MD
Pages 277-312 | Received 22 Dec 2010, Accepted 11 Apr 2011, Published online: 13 Jul 2011

References

  • Adam O, Auperin A, Wilquin F, Bourhis JH, Gachot B, Chachaty E. (2004). Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin Infect Dis, 38, 917–20.
  • Althoff Souza C, Muller NL, Marchiori E, Escuissato DL, Franquet T. (2006). Pulmonary invasive aspergillosis and candidiasis in immunocompromised patients: a comparative study of the high-resolution CT findings. J Thorac Imaging, 21, 184–9.
  • Alvarez F, Bandi V, Stager C, Guntupalli KK. (1997). Detection of Pneumocystis carinii in tracheal aspirates of intubated patients using calcofluor-white (Fungi-Fluor) and immunofluorescence antibody (Genetic Systems) stains. Crit Care Med, 25, 948–52.
  • Arendrup MC, Bergmann OJ, Larsson L, Nielsen HV, Jarlov JO, Christensson B. (2010). Detection of candidaemia in patients with and without underlying haematological disease. Clin Microbiol Infect, 16, 855–62.
  • Aronson MD, Bor DH. (1987). Blood cultures. Ann Intern Med, 106, 246–53.
  • Avet J, Jr., Granjon D, Prevot-Bitot N, Isnardi V, Berger C, Stephan JL, Dubois F. (2009). Monitoring of systemic candidiasis by 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging, 36, 1900.
  • Azoulay E, Bergeron A, Chevret S, Bele N, Schlemmer B, Menotti J. (2009). Polymerase chain reaction for diagnosing Pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. Chest, 135, 655–61.
  • Balajee SA, Borman AM, Brandt ME, Cano J, Cuenca-Estrella M, Dannaoui E, Guarro J, Haase G, Kibbler CC, Meyer W, O’Donnell K, Petti CA, Rodriguez-Tudela JL, Sutton D, Velegraki A, Wickes BL. (2009). Sequence-based identification of Aspergillus, Fusarium, and Mucorales species in the clinical mycology laboratory: where are we and where should we go from here? J Clin Microbiol, 47, 877–84.
  • Bassetti M, Righi E, Costa A, Fasce R, Molinari MP, Rosso R, Pallavicini FB, Viscoli C. (2006). Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis, 6, 21.
  • Blair JE, Coakley B, Santelli AC, Hentz JG, Wengenack NL. (2006). Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts. Mycopathologia, 162, 317–24.
  • Blair JE, Currier JT. (2008). Significance of isolated positive IgM serologic results by enzyme immunoassay for coccidioidomycosis. Mycopathologia, 166, 77–82.
  • Blevins LB, Fenn J, Segal H, Newcomb-Gayman P, Carroll KC. (1995). False-positive cryptococcal antigen latex agglutination caused by disinfectants and soaps. J Clin Microbiol, 33, 1674–5.
  • Blum U, Windfuhr M, Buitrago-Tellez C, Sigmund G, Herbst EW, Langer M. (1994). Invasive pulmonary aspergillosis. MRI, CT, and plain radiographic findings and their contribution for early diagnosis. Chest, 106, 1156–61.
  • Bodey GP. (1988). The emergence of fungi as major hospital pathogens. J Hosp Infect, 11 Suppl A, 411–26.
  • Boiselle PM, Crans CA, Jr., Kaplan MA. (1999). The changing face of Pneumocystis carinii pneumonia in AIDS patients. AJR Am J Roentgenol, 172, 1301–9.
  • Bollee G, Sarfati C, Thiery G, Bergeron A, de Miranda S, Menotti J, de Castro N, Tazi A, Schlemmer B, Azoulay E. (2007). Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients. Chest, 132, 1305–10.
  • Botterel F, Farrugia C, Ichai P, Costa JM, Saliba F, Bretagne S. (2008). Real-time PCR on the first galactomannan-positive serum sample for diagnosing invasive aspergillosis in liver transplant recipients. Transpl Infect Dis, 10, 333–8.
  • Boutboul F, Alberti C, Leblanc T, Sulahian A, Gluckman E, Derouin F, Ribaud P. (2002). Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease. Clin Infect Dis, 34, 939–43.
  • Bow EJ. (2009). Invasive fungal infection in haematopoietic stem cell transplant recipients: epidemiology from the transplant physician’s viewpoint. Mycopathologia, 168, 283–97.
  • Bross J, Talbot GH, Maislin G, Hurwitz S, Strom BL. (1989). Risk factors for nosocomial candidemia: a case-control study in adults without leukemia. Am J Med, 87, 614–20.
  • Buchheidt D, Hummel M, Schleiermacher D, Spiess B, Schwerdtfeger R, Cornely OA, Wilhelm S, Reuter S, Kern W, Sudhoff T, Morz H, Hehlmann R. (2004). Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol, 125, 196–202.
  • Buff SJ, McLelland R, Gallis HA, Matthay R, Putman CE. (1982). Candida albicans pneumonia: radiographic appearance. AJR Am J Roentgenol, 138, 645–8.
  • Caillot D, Casasnovas O, Bernard A, Couaillier JF, Durand C, Cuisenier B, Solary E, Piard F, Petrella T, Bonnin A, Couillault G, Dumas M, Guy H. (1997). Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol, 15, 139–47.
  • Caira M, Mancinelli M, Leone G, Pagano L. (2011). Invasive aspergillosis in acute leukemias: old and new risk factors and epidemiological trends. Med Mycol, 49 Suppl 1, S13–6.
  • Campa D, Tavanti A, Gemignani F, Mogavero CS, Bellini I, Bottari F, Barale R, Landi S, Senesi S. (2008). DNA microarray based on arrayed-primer extension technique for identification of pathogenic fungi responsible for invasive and superficial mycoses. J Clin Microbiol, 46, 909–15.
  • Capone D, Marchiori E, Wanke B, Dantas KE, Cavalcanti MA, Deus Filho A, Escuissato DL, Warszawiak D. (2008). Acute pulmonary coccidioidomycosis: CT findings from 15 patients. Br J Radiol, 81, 721–4.
  • Carrafiello G, Lagana D, Nosari AM, Guffanti C, Morra E, Recaldini C, D’Alba MJ, Sonvico U, Vanzulli A, Fugazzola C. (2006). Utility of computed tomography. (CT) and of fine needle aspiration biopsy. (FNAB) in early diagnosis of fungal pulmonary infections. Study of infections from filamentous fungi in haematologically immunodeficient patients. Radiol Med, 111, 33–41.
  • Chan CM, Woo PC, Leung AS, Lau SK, Che XY, Cao L, Yuen KY. (2002). Detection of antibodies specific to an antigenic cell wall galactomannoprotein for serodiagnosis of Aspergillus fumigatus aspergillosis. J Clin Microbiol, 40, 2041–5.
  • Chang WC, Tzao C, Hsu HH, Lee SC, Huang KL, Tung HJ, Chen CY. (2006). Pulmonary cryptococcosis: comparison of clinical and radiographic characteristics in immunocompetent and immunocompromised patients. Chest, 129, 333–40.
  • Chiller TM,Galgiani JN, Stevens DA. (2003). Coccidioidomycosis. Infect Dis Clin North Am, 17, 41–57
  • Chow JK, Golan Y, Ruthazer R, Karchmer AW, Carmeli Y, Lichtenberg DA, Chawla V, Young JA, Hadley S. (2008). Risk factors for albicans and non-albicans candidemia in the intensive care unit. Crit Care Med, 36, 1993–8.
  • Christensson B, Sigmundsdottir G, Larsson L. (1999). D-arabinitol–a marker for invasive candidiasis. Med Mycol, 37, 391–6.
  • Conces DJ, Jr. (1999). Endemic fungal pneumonia in immunocompromised patients. J Thorac Imaging, 14, 1–8.
  • Cornet M, Fleury L, Maslo C, Bernard JF, Brucker G. (2002). Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. J Hosp Infect, 51, 288–96.
  • Crawford SW, Hackman RC, Clark JG. (1989). Biopsy diagnosis and clinical outcome of persistent focal pulmonary lesions after marrow transplantation. Transplantation, 48, 266–71.
  • Cruciani M, Marcati P, Malena M, Bosco O, Serpelloni G, Mengoli C. (2002). Meta-analysis of diagnostic procedures for Pneumocystis carinii pneumonia in HIV-1-infected patients. Eur Respir J, 20, 982–9.
  • Cuenca-Estrella M, Meije Y, Diaz-Pedroche C, Gomez-Lopez A, Buitrago MJ, Bernal-Martinez L, Grande C, Juan RS, Lizasoain M, Rodriguez-Tudela JL, Aguado JM. (2009). Value of serial quantification of fungal DNA by a real-time PCR-based technique for early diagnosis of invasive aspergillosis in patients with febrile neutropenia. J Clin Microbiol, 47, 379–84.
  • Daly A, McAfee S, Dey B, Colby C, Schulte L, Yeap B, Sackstein R, Tarbell NJ, Sachs D, Sykes M, Spitzer TR. (2003). Nonmyeloablative bone marrow transplantation: Infectious complications in 65 recipients of HLA-identical and mismatched transplants. Biol Blood Marrow Transplant, 9, 373–82.
  • Datta K, Bartlett KH, Baer R, Byrnes E, Galanis E, Heitman J, Hoang L, Leslie MJ, MacDougall L, Magill SS, Morshed MG, Marr KA. (2009). Spread of Cryptococcus gattii into Pacific Northwest region of the United States. Emerg Infect Dis, 15, 1185–91.
  • Dawson-Saunders B, Trapp RG.(1990). Basic and Clinical Biostatistics, Norwalk, Appleton and Lange.
  • de Oliveira A, Unnasch TR, Crothers K, Eiser S, Zucchi P, Moir J, Beard CB, Lawrence GG, Huang L. (2007). Performance of a molecular viability assay for the diagnosis of Pneumocystis pneumonia in HIV-infected patients. Diagn Microbiol Infect Dis, 57, 169–76.
  • De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Munoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE. (2008). Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis, 46, 1813–21.
  • Denning DW, Marinus A, Cohen J, Spence D, Herbrecht R, Pagano L, Kibbler C, Kcrmery V, Offner F, Cordonnier C, Jehn U, Ellis M, Collette L, Sylvester R. (1998). An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. J Infect, 37, 173–80.
  • Denning DW, Stevens DA. (1990). Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis, 12, 1147–201.
  • Denning DW, Stevens DA, Hamilton JR. (1990). Comparison of Guizotia abyssinica seed extract (“bird seed”) agar with conventional media for selective identification of Cryptococcus neoformans in patients with AIDS. J Clin Microbiol, 28, 2565–7.
  • Digby J, Kalbfleisch J, Glenn A, Larsen A, Browder W, Williams D. (2003). Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol, 10, 882–5.
  • Donnelly JP, Leeflang MM. (2010). Galactomannan detection and diagnosis of invasive aspergillosis. Clin Infect Dis, 50, 1070–1; author reply 1071-2.
  • Dubois PJ, Myerowitz RL, Allen CM. (1977). Pathoradiologic correlation of pulmonary candidiasis in immunosuppressed patients. Cancer, 40, 1026–36.
  • Durkin M, Witt J, Lemonte A, Wheat B, Connolly P. (2004). Antigen assay with the potential to aid in diagnosis of blastomycosis. J Clin Microbiol, 42, 4873–5.
  • Duthie R, Denning DW. (1995). Aspergillus fungemia: report of two cases and review. Clin Infect Dis, 20, 598–605.
  • Einsele H, Hebart H, Roller G, Loffler J, Rothenhofer I, Muller CA, Bowden RA, van Burik J, Engelhard D, Kanz L, Schumacher U. (1997). Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol, 35, 1353–60.
  • Eucker J, Sezer O, Graf B, Possinger K. (2001). Mucormycoses. Mycoses, 44, 253–60.
  • Evans EG, Richardson MD, Odds FC Holland KT. (1973). Relevance of antigenicity of Candida albicans growth phases to diagnosis of systemic candidiasis. Br Med J, 4, 86–7.
  • Falcone M, Massetti AP, Russo A, Vullo V, Venditti M. (2011). Invasive aspergillosis in patients with liver disease. Med Mycol,49,406–13.
  • Festic E, Gajic O, Limper AH, Aksamit TR. (2005). Acute respiratory failure due to Pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features. Chest, 128, 573–9.
  • Filice G, Yu B, Armstrong D. (1977). Immunodiffusion and agglutination tests for Candida in patients with neoplastic disease: inconsistent correlation of results with invasive infections. J Infect Dis, 135, 349–57.
  • Finkelman MA. (2010) Pneumocystis jirovecii infection: cell wall (1-3)-β-D-glucan biology and diagnostic utility. Crit Rev Microbiol 36,271–81.
  • Fischler DF, Hall GS, Gordon S, Stoler MH, Nunez C. (1997). Aspergillus in cytology specimens: a review of 45 specimens from 36 patients. Diagn Cytopathol, 16, 26–30.
  • Flori P, Bellete B, Durand F, Raberin H, Cazorla C, Hafid J, Lucht F, Sung RT. (2004). Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens. J Med Microbiol, 53, 603–7.
  • Fox DL, Muller NL. (2005). Pulmonary cryptococcosis in immunocompetent patients: CT findings in 12 patients. AJR Am J Roentgenol, 185, 622–6.
  • Francis P, Lee JW, Hoffman A, Peter J, Francesconi A, Bacher J, Shelhamer J, Pizzo PA, Walsh TJ. (1994). Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection. J Infect Dis, 169, 356–68.
  • Franquet T, Muller NL, Lee KS, Oikonomou A, Flint JD. (2005). Pulmonary candidiasis after hematopoietic stem cell transplantation: thin-section CT findings. Radiology, 236, 332–7.
  • Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. (1992). Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis, 15, 414–21.
  • Fricker-Hidalgo H, Chazot F, Lebeau B, Pelloux H, Ambroise-Thomas P, Grillot R. (1998). Use of simulated blood cultures to compare a specific fungal medium with a standard microorganism medium for yeast detection. Eur J Clin Microbiol Infect Dis, 17, 113–6.
  • Fujisawa T, Suda T, Matsuda H, Inui N, Nakamura Y, Sato J, Toyoshima M, Nakano Y, Yasuda K, Gemma H, Hayakawa H, Chida K. (2009). Real-time PCR is more specific than conventional PCR for induced sputum diagnosis of Pneumocystis pneumonia in immunocompromised patients without HIV infection. Respirology, 14, 203–9.
  • Gamsu G, Hecht ST, Birnberg FA, Coleman DL, Golden JA. (1982). Pneumocystis carinii pneumonia in homosexual men. AJR Am J Roentgenol, 139, 647–51.
  • Geraghty PR, Kee ST, McFarlane G, Razavi MK, Sze DY, Dake MD. (2003). CT-guided transthoracic needle aspiration biopsy of pulmonary nodules: needle size and pneumothorax rate. Radiology, 229, 475–81.
  • Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ Cassileth PA. (1984). Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med, 100, 345–51.
  • Greene RE, Schlamm HT, Oestmann JW, Stark P, Durand C, Lortholary O, Wingard JR, Herbrecht R, Ribaud P, Patterson TF, Troke PF, Denning DW, Bennett JE, de Pauw BE, Rubin RH. (2007). Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis, 44, 373–9.
  • Grow WB, Moreb JS, Roque D, Manion K, Leather H, Reddy V, Khan SA, Finiewicz KJ, Nguyen H, Clancy CJ, Mehta PS, Wingard JR. (2002). Late onset of invasive Aspergillus infection in bone marrow transplant patients at a university hospital. Bone Marrow Transplant, 29, 15–9.
  • Gruden JF, Huang L, Turner J, Webb WR, Merrifield C, Stansell JD, Gamsu G, Hopewell PC. (1997). High-resolution CT in the evaluation of clinically suspected Pneumocystis carinii pneumonia in AIDS patients with normal, equivocal, or nonspecific radiographic findings. AJR Am J Roentgenol, 169, 967–75.
  • Guinea J, Torres-Narbona M, Gijon P, Munoz P, Pozo F, Pelaez T, de Miguel J, Bouza E. (2010). Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect, 16, 870–7.
  • Guo YL, Chen YQ, Wang K, Qin SM, Wu C, Kong JL. (2010). Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review. Chest, 138, 817–24.
  • Gupta R, Mirdha BR, Guleria R, Mohan A, Agarwal SK, Kumar L, Kabra SK, Samantaray JC. (2007). Improved detection of Pneumocystis jirovecii infection in a tertiary care reference hospital in India. Scand J Infect Dis, 39, 571–6.
  • Hage CA, Bowyer S, Tarvin SE, Helper D, Kleiman MB, Wheat LJ. (2010a). Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy. Clin Infect Dis, 50, 85–92.
  • Hage CA, Davis TE, Fuller D, Egan L, Witt JR, 3rd Wheat, LJ, Knox KS. (2010b). Diagnosis of histoplasmosis by antigen detection in BAL fluid. Chest, 137, 623–8.
  • Hamaki T, Kami M, Kanda Y, Miyakoshi S, Ueyama J, Morinaga S, Mutou Y. (2001). False-positive results of Aspergillus enzyme-linked immunosorbent assay in a patient with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant, 28, 633–4.
  • Hamilton JR, Noble A, Denning DW, Stevens DA. (1991). Performance of cryptococcus antigen latex agglutination kits on serum and cerebrospinal fluid specimens of AIDS patients before and after pronase treatment. J Clin Microbiol, 29, 333–9.
  • Hartman TE, Primack SL, Muller NL, Staples CA. (1994). Diagnosis of thoracic complications in AIDS: accuracy of CT. AJR Am J Roentgenol, 162, 547–53.
  • Haynes KA, Latge JP, Rogers TR. (1990). Detection of Aspergillus antigens associated with invasive infection. J Clin Microbiol, 28, 2040–4.
  • Hebart H, Loffler J, Meisner C, Serey F, Schmidt D, Bohme A, Martin H, Engel A, Bunje D, Kern WV, Schumacher U, Kanz L, Einsele H. (2000). Early detection of Aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening. J Infect Dis, 181, 1713–9.
  • Hidalgo A, Falco V, Mauleon S, Andreu J, Crespo M, Ribera E, Pahissa A, Caceres J. (2002). Accuracy of high-resolution CT in distinguishing between Pneumocystis carinii pneumonia and non-Pneumocystis carinii pneumonia in AIDS patients. Eur Radiol, 13, 1179–84.
  • Ho AY, Pagliuca A, Maisey MN, Mufti GJ. (1998). Positron emission scanning with 18-FDG in the diagnosis of deep fungal infections. Br J Haematol, 101, 392–3.
  • Horn DL, Fishman JA, Steinbach WJ, Anaissie EJ, Marr KA, Olyaei AJ, Pfaller MA, Weiss MA, Webster KM, Neofytos D. (2007). Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections. Diagn Microbiol Infect Dis, 59, 407–14.
  • Horvath JA, Dummer S. (1996). The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med, 100, 171–8.
  • Hot A, Maunoury C, Poiree S, Lanternier F, Viard JP, Loulergue P, Coignard H, Bougnoux ME, Suarez F, Rubio MT, Malhaoui N, Dupont B, Lecuit M, Faraggi M, Lortholary O. (2011). Diagnostic contribution of the positron emission scanning with 18F-FDG for invasive fungal infections. Clin Microbiol Infect,17,409–17.
  • Hsu JL, Holodniy M, Clemons KV, Liu M, Stevens DA. (2010). Application of novel biosensors for Aspergillus diagnosis. Pathways to Improving Diagnostics of Invasive Aspergillosis. Bethesda, Abstract/poster no. 2.
  • Hsu JL, Kuschner WG, Paik J, Bower ND, Kothary N. (2011). The diagnostic yield of CT-guided percutaneous lung biopsy in solid organ transplant recipients. Society of Interventional Radiology Conference, Chicago, Abstract/poster.
  • Huang A, Li JW, Shen ZQ, Wang XW, Jin M. (2006). High-throughput identification of clinical pathogenic fungi by hybridization to an oligonucleotide microarray. J Clin Microbiol, 44, 3299–305.
  • Huang L, Crothers K. (2009). HIV-associated opportunistic pneumonias. Respirology, 14, 474–85.
  • Hurst SF, Reyes GH, McLaughlin DW, Reiss E, Morrison CJ. (2000). Comparison of commercial latex agglutination and sandwich enzyme immunoassays with a competitive binding inhibition enzyme immunoassay for detection of antigenemia and antigenuria in a rabbit model of invasive aspergillosis. Clin Diagn Lab Immunol, 7, 477–85.
  • Huston SM, Mody CH. (2009). Cryptococcosis: an emerging respiratory mycosis. Clin Chest Med, 30, 253–64.
  • Ibanez-Nolla J, Torres-Rodriguez JM, Nolla M, Leon MA, Mendez R, Soria G, Diaz RM, Marrugat J. (2001). The utility of serology in diagnosing candidosis in non-neutropenic critically ill patients. Mycoses, 44, 47–53.
  • Igai H, Gotoh M, Yokomise H. (2006). Computed tomography (CT) and positron emission tomography with [18F]fluoro-2-deoxy-D-glucose (FDG-PET) images of pulmonary cryptococcosis mimicking lung cancer. Eur J Cardiothorac Surg, 30, 837–9.
  • Iruretagoyena JR, Regulez P, Quindos G, Ponton J. (2000). Antibodies to Candida albicans germ tubes in two intensive care patients with invasive candidiasis. Rev Iberoam Micol, 17, 93–6.
  • Ives NJ, Gazzard BG, Easterbrook PJ. (2001). The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART) in a London clinic. J Infect, 42, 134–9.
  • Jamadar DA, Kazerooni EA, Daly BD, White CS, Gross BH. (1995). Pulmonary zygomycosis: CT appearance. J Comput Assist Tomogr, 19, 733–8.
  • Jantunen E, Salonen J, Juvonen E, Koivunen E, Siitonen T, Lehtinen T, Kuittinen O, Leppa S, Anttila VJ, Itala M, Wiklund T, Remes K, Nousiainen T. (2004). Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients. Eur J Haematol, 73, 174–8.
  • Jarboui MA, Sellami A, Sellami H, Cheikhrouhou F, Makni F, Ben Arab N, Ben Jemaa M, Ayadi A. (2010). Molecular diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients. Mycoses, 53, 329–33.
  • Jaye DL, Waites KB, Parker B, Bragg SL, Moser SA. (1998). Comparison of two rapid latex agglutination tests for detection of cryptococcal capsular polysaccharide. Am J Clin Pathol, 109, 634–41.
  • Jones JM. (1990). Laboratory diagnosis of invasive candidiasis. Clin Microbiol Rev, 3, 32–45.
  • Jorda-Marcos R, Alvarez-Lerma F, Jurado M, Palomar M, Nolla-Salas J, Leon MA, Leon C. (2007). Risk factors for candidaemia in critically ill patients: a prospective surveillance study. Mycoses, 50, 302–10.
  • Junghanss C, Marr KA, Carter RA, Sandmaier BM, Maris MB, Maloney DG, Chauncey T, McSweeney PA, Storb R. (2002). Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study. Biol Blood Marrow Transplant, 8, 512–20.
  • Kahn FW, Jones JM, England DM. (1986). The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis. Am J Clin Pathol, 86, 518–23.
  • Kallenberg MH, Gill RR, Factor RE, Bryar JM, Rubin RH, Jacobson FL, Marty FM. (2009). Diagnostic efficacy and safety of computed tomography-guided transthoracic needle biopsy in patients with hematologic malignancies. Acad Radiol, 16, 1408–15.
  • Kami M, Fukui T, Ogawa S, Kazuyama Y, Machida U, Tanaka Y, Kanda Y, Kashima T, Yamazaki Y, Hamaki T, Mori S, Akiyama H, Mutou Y, Sakamaki H, Osumi K, Kimura S, Hirai H. (2001). Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis, 33, 1504–12.
  • Kauffman CA. (2007). Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev, 20, 115–32.
  • Kawazu M, Kanda Y, Nannya Y, Aoki K, Kurokawa M, Chiba S, Motokura T, Hirai H, Ogawa S. (2004). Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1–>3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol, 42, 2733–41.
  • Klingspor L, Loeffler J. (2009). Aspergillus PCR formidable challenges and progress. Med Mycol, 47 Suppl 1, S241–7.
  • Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, Safdar A, Kantarjian H, Champlin R, Walsh TJ, Raad II. (2005). Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis, 191, 1350–60.
  • Kontoyiannis DP, Sumoza D, Tarrand J, Bodey GP, Storey R, Raad, II. (2000). Significance of aspergillemia in patients with cancer: a 10-year study. Clin Infect Dis, 31, 188–9.
  • Koo S, Bryar JM, Page JH, Baden LR, Marty FM. (2009). Diagnostic performance of the. (1–>3)-beta-D-glucan assay for invasive fungal disease. Clin Infect Dis, 49, 1650–9.
  • Kosmin AR, Fekete T. (2008). Use of fungal blood cultures in an academic medical center. J Clin Microbiol, 46, 3800–1.
  • Krajicek BJ, Thomas CF, Jr., Limper AH.(2009). Pneumocystis pneumonia: current concepts in pathogenesis, diagnosis, and treatment. Clin Chest Med, 30, 265–78.
  • Kralovic SM, Rhodes JC. (1998). Utility of routine testing of bronchoalveolar lavage fluid for cryptococcal antigen. J Clin Microbiol, 36, 3088–9.
  • Kuhlman JE, Fishman EK, Siegelman SS. (1985). Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology, 157, 611–4.
  • Kwon-Chung KJ, Polacheck I, Bennett JE. (1982). Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol, 15, 535–7.
  • Lain A, Moragues MD, Ruiz JC, Mendoza J, Camacho A, Del Palacio A, Ponton J. (2007). Evaluation of a novel enzyme-linked immunosorbent assay to detect immunoglobulin G antibody to enolase for serodiagnosis of invasive candidiasis. Clin Vaccine Immunol, 14, 318–9.
  • LaRocque RC, Katz JT, Perruzzi P, Baden LR. (2003). The utility of sputum induction for diagnosis of Pneumocystis pneumonia in immunocompromised patients without human immunodeficiency virus. Clin Infect Dis, 37, 1380–3.
  • Lass-Flörl C, Gunsilius E, Gastl G, Englisch M, Koch G, Ulmer H, Dierich MP, Petzer A. (2003). Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution. Ann Hematol, 82, 565–9.
  • Lass-Flörl C, Salzer GM, Schmid T, Rabl W, Ulmer H, Dierichi MP. (1999). Pulmonary Aspergillus colonization in humans and its impact on management of critically ill patients. Br J Haematol, 104, 745–7.
  • Leber B, Mayrhauser U, Rybczynski M, Stadlbauer V. (2009). Innate immune dysfunction in acute and chronic liver disease. Wien Klin Wochenschr, 121, 732–44.
  • Lee FY, Mossad SB, Adal KA. (1999). Pulmonary mucormycosis: the last 30 years. Arch Intern Med, 159, 1301–9.
  • Lee YR, Choi YW, Lee KJ, Jeon SC, Park CK, Heo JN. (2005). CT halo sign: the spectrum of pulmonary diseases. Br J Radiol, 78, 862–5.
  • Lehrer RI, Howard DH, Sypherd PS, Edwards JE, Segal GP, Winston DJ. (1980). Mucormycosis. Ann Intern Med, 93, 93–108.
  • Lehtonen L, Rantala A, Oksman P, Eerola E, Lehtonen OP. (1993). Determination of serum arabinitol levels by mass spectrometry in patients with postoperative candidiasis. Eur J Clin Microbiol Infect Dis, 12, 330–5.
  • Leinberger DM, Schumacher U, Autenrieth IB, Bachmann TT. (2005). Development of a DNA microarray for detection and identification of fungal pathogens involved in invasive mycoses. J Clin Microbiol, 43, 4943–53.
  • Leon C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, Garnacho-Montero J, Leon MA. (2006). A bedside scoring system. (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med, 34, 730–7.
  • Leon C, Ruiz-Santana S, Saavedra P, Galvan B, Blanco A, Castro C, Balasini C, Utande-Vazquez A, Gonzalez de Molina FJ, Blasco-Navalproto MA, Lopez MJ, Charles PE, Martin E, Hernandez-Viera MA. (2009). Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med, 37, 1624–33.
  • Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O. (2009). Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France. (2005-2006). Crit Care Med, 37, 1612–8.
  • Levy H, Horak DA, Tegtmeier BR, Yokota SB, Forman SJ. (1992). The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Respir Med, 86, 243–8.
  • Libanore M, Prini E, Mazzetti M, Barchi E, Raise E, Gritti FM, Bonazzi L, Ghinelli F. (2002). Invasive aspergillosis in Italian AIDS patients. Infection, 30, 341–5.
  • Lin SJ, Schranz J, Teutsch SM. (2001). Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis, 32, 358–66.
  • Linares MJ, Javier MR, Villanueva JL, Solis F, Torre-Cisneros J, Rodriguez F, Kindelan JM, Casal M. (2001). Detection of antibodies to Candida albicans germ tubes in heroin addicts with systemic candidiasis. Clin Microbiol Infect, 7, 218–26.
  • Lindell RM, Hartman TE, Nadrous HF, Ryu JH. (2005). Pulmonary cryptococcosis: CT findings in immunocompetent patients. Radiology, 236, 326–31.
  • Lipke AB, Mihas AA. (2007). Non-decompensated cirrhosis as a risk factor for invasive aspergillosis: a case report and review of the immune dysfunction of cirrhosis. Am J Med Sci, 334, 314–6.
  • Loeffler J, Hebart H, Bialek R, Hagmeyer L, Schmidt D, Serey FP, Hartmann M, Eucker J, Einsele H. (1999). Contaminations occurring in fungal PCR assays. J Clin Microbiol, 37, 1200–2.
  • Loeffler J, Henke N, Hebart H, Schmidt D, Hagmeyer L, Schumacher U, Einsele H. (2000). Quantification of fungal DNA by using fluorescence resonance energy transfer and the light cycler system. J Clin Microbiol, 38, 586–90.
  • Loffler J, Hebart H, Schumacher U, Reitze H, Einsele H. (1997). Comparison of different methods for extraction of DNA of fungal pathogens from cultures and blood. J Clin Microbiol, 35, 3311–2.
  • Louie RF, Tang Z, Albertson TE, Cohen S, Tran NK, Kost GJ. (2008). Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia. Crit Care Med, 36, 1487–92.
  • Maertens J, Buve K, Theunissen K, Meersseman W, Verbeken E, Verhoef G, Van Eldere J, Lagrou K. (2009). Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients. Cancer, 115, 355–62.
  • Maertens J, Theunissen K, Verbeken E, Lagrou K, Verhaegen J, Boogaerts M, Eldere JV. (2004). Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol, 126, 852–60.
  • Maertens J, Van Eldere J, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M. (2002). Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis, 186, 1297–306.
  • Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. (2001). Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood, 97, 1604–10.
  • Mancini N, Carletti S, Ghidoli N, Cichero P, Burioni R, Clementi M. (2010). The era of molecular and other non-culture-based methods in diagnosis of sepsis. Clin Microbiol Rev, 23, 235–51.
  • Marr KA, Patterson T, Denning D. (2002). Aspergillosis. Pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am, 16, 875–94.
  • Martin GS, Mannino DM, Eaton S, Moss M. (2003). The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med, 348, 1546–54.
  • Marty FM, Koo S. (2009). Role of (1–>3)-beta-D-glucan in the diagnosis of invasive aspergillosis. Med Mycol, 47 Suppl 1, S233–40.
  • Marty FM, Lowry CM, Lempitski SJ, Kubiak DW, Finkelman MA, Baden LR. (2006). Reactivity of (1–>3)-beta-d-glucan assay with commonly used intravenous antimicrobials. Antimicrob Agents Chemother, 50, 3450–3.
  • McAdams HP, Rosado de Christenson M, Strollo DC, Patz EF, Jr. (1997). Pulmonary mucormycosis: radiologic findings in 32 cases. AJR Am J Roentgenol, 168, 1541–8.
  • McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Plikaytis BD, Warnock DW. (2001). Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis, 33, 641–7.
  • Meersseman W, Lagrou K, Maertens J, Wilmer A, Hermans G, Vanderschueren S, Spriet I, Verbeken E, Van Wijngaerden E. (2008). Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med, 177, 27–34.
  • Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E. (2004). Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med, 170, 621–5.
  • Megson GM, Stevens DA, Hamilton JR, Denning DW. (1996). D-mannitol in cerebrospinal fluid of patients with AIDS and cryptococcal meningitis. J Clin Microbiol, 34, 218–21.
  • Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP. (2009). Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis, 9, 89–96.
  • Merz WG, Evans GL, Shadomy S, Anderson S, Kaufman L, Kozinn PJ, Mackenzie DW, Protzman WP, Remington JS. (1977). Laboratory evaluation of serological tests for systemic candidiasis: a cooperative study. J Clin Microbiol, 5, 596–603.
  • Meyer MH, Letscher-Bru V, Jaulhac B, Waller J, Candolfi E. (2004). Comparison of Mycosis IC/F and plus Aerobic/F media for diagnosis of fungemia by the bactec 9240 system. J Clin Microbiol, 42, 773–7.
  • Meyohas MC, Roux P, Bollens D, Chouaid C, Rozenbaum W, Meynard JL, Poirot JL, Frottier J, Mayaud C. (1995). Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS. Clin Infect Dis, 21, 628–33.
  • Millon L, Barale T, Julliot MC, Martinez J, Mantion G. (1995). Interference by hydroxyethyl starch used for vascular filling in latex agglutination test for cryptococcal antigen. J Clin Microbiol, 33, 1917–9.
  • Millon L, Piarroux R, Deconinck E, Bulabois CE, Grenouillet F, Rohrlich P, Costa JM, Bretagne S. (2005). Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis. J Clin Microbiol, 43, 5097–101.
  • Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, Gardner T, Sattah M, de Leon GP, Baughman W, Hajjeh RA. (2003). The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis, 36, 789–94.
  • Mitsutake K, Miyazaki T, Tashiro T, Yamamoto Y, Kakeya H, Otsubo T, Kawamura S, Hossain MA, Noda T, Hirakata Y, Kohno S. (1996). Enolase antigen, mannan antigen, Cand-Tec antigen, and beta-glucan in patients with candidemia. J Clin Microbiol, 34, 1918–21.
  • Montoya JG, Chaparro SV, Celis D, Cortes JA, Leung AN, Robbins RC, Stevens DA. (2003). Invasive aspergillosis in the setting of cardiac transplantation. Clin Infect Dis, 37 Suppl 3, S281–92.
  • Mori M, Galvin JR, Barloon TJ, Gingrich RD, Stanford W. (1991). Fungal pulmonary infections after bone marrow transplantation: evaluation with radiography and CT. Radiology, 178, 721–6.
  • Morrell M, Fraser VJ, Kollef MH. (2005). Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother, 49, 3640–5.
  • Morrell RM, Jr., Wasilauskas BL, Steffee CH. (1996). Performance of fungal blood cultures by using the Isolator collection system: is it cost-effective? J Clin Microbiol, 34, 3040–3.
  • Nadrous HF, Antonios VS, Terrell CL, Ryu JH. (2003). Pulmonary cryptococcosis in nonimmunocompromised patients. Chest, 124, 2143–7.
  • Nakazato T, Mihara A, Sanada Y, Suzuki K, Aisa Y, Iwabuchi M, Kakimoto T. (2010). Pneumocystis jiroveci pneumonia detected by FDG-PET. Ann Hematol, 89, 839–40.
  • Nalesnik MA, Myerowitz RL, Jenkins R, Lenkey J, Herbert D. (1980). Significance of Aspergillus species isolated from respiratory secretions in the diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol, 11, 370–6.
  • Nguyen BD. (2006). F-18 FDG PET/CT imaging of disseminated coccidioidomycosis. Clin Nucl Med, 31, 568–71.
  • Nguyen MH, Jaber R, Leather HL, Wingard JR, Staley B, Wheat LJ, Cline CL, Baz M, Rand KH, Clancy CJ. (2007). Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts. J Clin Microbiol, 45, 2787–92.
  • Nosari A, Anghilieri M, Carrafiello G, Guffanti C, Marbello L, Montillo M, Muti G, Ribera S, Vanzulli A, Nichelatti M, Morra E. (2003). Utility of percutaneous lung biopsy for diagnosing filamentous fungal infections in hematologic malignancies. Haematologica, 88, 1405–9.
  • Nucci M, Anaissie E. (2007). Fusarium infections in immunocompromised patients. Clin Microbiol Rev, 20, 695–704.
  • Obayashi T, Negishi K, Suzuki T, Funata N. (2008). Reappraisal of the serum. (1–>3)-beta-D-glucan assay for the diagnosis of invasive fungal infections–a study based on autopsy cases from 6 years. Clin Infect Dis, 46, 1864–70.
  • Obayashi T, Yoshida M, Mori T, Goto H, Yasuoka A, Iwasaki H, Teshima H, Kohno S, Horiuchi A, Ito A et al.. (1995). Plasma (1–>3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet, 345, 17–20.
  • Okamoto K, Yamamoto T, Nonaka D, Shin H, Okada K, Hayashi J, Kashiwagi S. (1998). Plasma (1–>3)-beta-D-glucan measurement and polymerase chain reaction on sputum as practical parameters in Pneumocystis carinii pneumonia. Intern Med, 37, 618–21.
  • Oliveira K, Haase G, Kurtzman C, Hyldig-Nielsen JJ, Stender H. (2001). Differentiation of Candida albicans and Candida dubliniensis by fluorescent in situ hybridization with peptide nucleic acid probes. J Clin Microbiol, 39, 4138–41.
  • Ostrosky-Zeichner L, Alexander BD, Kett DH, Vazquez J, Pappas PG, Saeki F, Ketchum PA, Wingard J, Schiff R, Tamura H, Finkelman MA, Rex JH. (2005). Multicenter clinical evaluation of the (1–>3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis, 41, 654–9.
  • Ostrosky-Zeichner L, Sable C, Sobel J, Alexander BD, Donowitz G, Kan V, Kauffman CA, Kett D, Larsen RA, Morrison V, Nucci M, Pappas PG, Bradley ME, Major S, Zimmer L, Wallace D, Dismukes WE, Rex JH. (2007). Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis, 26, 271–6.
  • Pagano L, Fianchi L, Mele L, Girmenia C, Offidani M, Ricci P, Mitra ME, Picardi M, Caramatti C, Piccaluga P, Nosari A, Buelli M, Allione B, Cortelezzi A, Fabbiano F, Milone G, Invernizzi R, Martino B, Masini L, Todeschini G, Cappucci MA, Russo D, Corvatta L, Martino P, Del Favero A. (2002). Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years’ experience of infection in GIMEMA centres. Br J Haematol, 117, 379–86.
  • Paphitou NI, Ostrosky-Zeichner L, Rex JH. (2005). Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials. Med Mycol, 43, 235–43.
  • Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, Anaissie EJ, Brumble LM, Herwaldt L, Ito J, Kontoyiannis DP, Lyon GM, Marr KA, Morrison VA, Park BJ, Patterson TF, Perl TM, Oster RA, Schuster MG, Walker R, Walsh TJ, Wannemuehler KA, Chiller TM. (2010). Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis, 50, 1101–11.
  • Parish JM, Blair JE. (2008). Coccidioidomycosis. Mayo Clin Proc, 83, 343–48.
  • Patterson JE. (1999). Epidemiology of fungal infections in solid organ transplant patients. Transpl Infect Dis, 1, 229–36.
  • Pazos C, Ponton J, Del Palacio A. (2005). Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol, 43, 299–305.
  • Peman J, Zaragoza R. (2010). Current diagnostic approaches to invasive candidiasis in critical care settings. Mycoses, 53, 424–33.
  • Persat F, Ranque S, Derouin F, Michel-Nguyen A, Picot S, Sulahian A. (2008). Contribution of the (1–>3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol, 46, 1009–13.
  • Pfeiffer CD, Fine JP, Safdar N. (2006). Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis, 42, 1417–27.
  • Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. (1994). Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg, 220, 751–8.
  • Priola AM, Priola SM, Cataldi A, Errico L, Di Franco M, Campisi P, Molinaro L, Marci V, Novello S, Fava C. (2007). Accuracy of CT-guided transthoracic needle biopsy of lung lesions: factors affecting diagnostic yield. Radiol Med, 112, 1142–59.
  • Procop GW, Haddad S, Quinn J, Wilson ML, Henshaw NG, Reller LB, Artymyshyn RL, Katanik MT, Weinstein MP. (2004). Detection of Pneumocystis jiroveci in respiratory specimens by four staining methods. J Clin Microbiol, 42, 3333–5.
  • Prodanovic H, Cracco C, Massard J, Barrault C, Thabut D, Duguet A, Datry A, Derenne JP, Poynard T, Similowski T. (2007). Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series. BMC Gastroenterol, 7, 2.
  • Quindos G. (2006). New microbiological techniques for the diagnosis of invasive mycoses caused by filamentous fungi. Clin Microbiol Infect, 12 (suppl 7), 40–52.
  • Quindos G, Moragues MD, Ponton J. (2004). Is there a role for antibody testing in the diagnosis of invasive candidiasis? Rev Iberoam Micol, 21, 10–4.
  • Regge D, Gallo T, Galli J, Bertinetti A, Gallino C, Scappaticci E. (1997). Systemic arterial air embolism and tension pneumothorax: two complications of transthoracic percutaneous thin-needle biopsy in the same patient. Eur Radiol, 7, 173–5.
  • Reichenberger F, Habicht J, Matt P, Frei R, Soler M, Bolliger CT, Dalquen P, Gratwohl A, Tamm M. (1999). Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis. Bone Marrow Transplant, 24, 1195–9.
  • Reiss E, Morrison CJ. (1993). Nonculture methods for diagnosis of disseminated candidiasis. Clin Microbiol Rev, 6, 311–23.
  • Rifkind D, Faris TD, Hill RB, Jr. (1966). Pneumocystis carinii pneumonia. Studies on the diagnosis and treatment. Ann Intern Med, 65, 943–56.
  • Rodriguez-Tudela JL, Berenguer J, Guarro J, Kantarcioglu AS, Horre R, de Hoog GS, Cuenca-Estrella M. (2009). Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. Med Mycol, 47, 359–70.
  • Roebuck DJ, Fisher DA, Currie BJ. (1998). Cryptococcosis in HIV negative patients: findings on chest radiography. Thorax, 53, 554–7.
  • Rohner P, Jacomo V, Studer R, Schrenzel J, Graf JD. (2009). Detection of Pneumocystis jirovecii by two staining methods and two quantitative PCR assays. Infection, 37, 261–5.
  • Rolando N, Harvey F, Brahm J, Philpott-Howard J, Alexander G, Casewell M, Fagan E, Williams R. (1991). Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol, 12, 1–9.
  • Ruchel R, Schaffrinski M. (1999). Versatile fluorescent staining of fungi in clinical specimens by using the optical brightener Blankophor. J Clin Microbiol, 37, 2694–6.
  • Saha DC, Xess I, Jain N. (2008). Evaluation of conventional & serological methods for rapid diagnosis of cryptococcosis. Indian J Med Res, 127, 483–8.
  • Samarakoon P, Soubani AO. (2008). Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature. Chron Respir Dis, 5, 19–27.
  • Sarosi GA, Davies SF. (1996). Endemic mycosis complicating human immunodeficiency virus infection. West J Med, 164, 335–40.
  • Sarosi GA, Johnson PC. (1992). Disseminated histoplasmosis in patients infected with human immunodeficiency virus. Clin Infect Dis, 14 Suppl 1, S60–7.
  • Saubolle MA, McKellar PP, Sussland D. (2007). Epidemiologic, clinical, and diagnostic aspects of coccidioidomycosis. J Clin Microbiol, 45, 26–30.
  • Sekhon AS, Garg AK, Kaufman L, Kobayashi GS, Hamir Z, Jalbert M, Moledina N. (1993). Evaluation of a commercial enzyme immunoassay for the detection of cryptococcal antigen. Mycoses, 36, 31–4.
  • Sendid B, Jouault T, Coudriau R, Camus D, Odds F, Tabouret M, Poulain D. (2004). Increased sensitivity of mannanemia detection tests by joint detection of alpha- and beta-linked oligomannosides during experimental and human systemic candidiasis. J Clin Microbiol, 42, 164–71.
  • Sendid B, Poirot JL, Tabouret M, Bonnin A, Caillot D, Camus D, Poulain D. (2002). Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J Med Microbiol, 51, 433–42.
  • Sendid B, Tabouret M, Poirot JL, Mathieu D, Fruit J, Poulain D. (1999). New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis. J Clin Microbiol, 37, 1510–7.
  • Shepard JR, Addison RM, Alexander BD, Della-Latta P, Gherna M, Haase G, Hall G, Johnson JK, Merz WG, Peltroche-Llacsahuanga H, Stender H, Venezia RA, Wilson D, Procop GW, Wu F, Fiandaca MJ. (2008). Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles. J Clin Microbiol, 46, 50–5.
  • Shi JM, Cai Z, Huang H, Ye XJ, He JS, Xie WZ, Zhang J, Zhou XY, Luo Y, Lin Y, Li L, Zheng WY, Wei GQ, Lin MF. (2009). Role of CT-guided percutaneous lung biopsy in diagnosis of pulmonary fungal infection in patients with hematologic diseases. Int J Hematol, 89, 624–7.
  • Silveira FP, Husain S. (2007). Fungal infections in solid organ transplantation. Med Mycol, 45, 305–20.
  • Sing A, Trebesius K, Roggenkamp A, Russmann H, Tybus K, Pfaff F, Bogner JR, Emminger C, Heesemann J. (2000). Evaluation of diagnostic value and epidemiological implications of PCR for Pneumocystis carinii in different immunosuppressed and immunocompetent patient groups. J Clin Microbiol, 38, 1461–7.
  • Singh N. (2003). Fungal infections in the recipients of solid organ transplantation. Infect Dis Clin North Am, 17, 113–34.
  • Singh N, Obman A, Husain S, Aspinall S, Mietzner S, Stout JE. (2004). Reactivity of Platelia Aspergillus galactomannan antigen with piperacillin-tazobactam: clinical implications based on achievable concentrations in serum. Antimicrob Agents Chemother, 48, 1989–92.
  • Siwek GT, Dodgson KJ, de Magalhaes-Silverman M, Bartelt LA, Kilborn SB, Hoth PL, Diekema DJ, Pfaller MA. (2004). Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis, 39, 584–7.
  • Smith CE, Saito MT, Beard RR, Kepp RM, Clark RW, Eddie BU. (1950). Serological tests in the diagnosis and prognosis of coccidioidomycosis. Am J Hyg, 52, 1–21.
  • Smith CE, Saito MT, Simons SA. (1956). Pattern of 39,500 serologic tests in coccidioidomycosis. J Am Med Assoc, 160, 546–52.
  • Sojan SM, Chew G. (2005). Pneumocystis carinii pneumonia on F-18 FDG PET. Clin Nucl Med, 30, 763–4.
  • Speed B, Dunt D. (1995). Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis, 21, 28–34.
  • Spiess B, Seifarth W, Hummel M, Frank O, Fabarius A, Zheng C, Morz H, Hehlmann R, Buchheidt D. (2007). DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients. J Clin Microbiol, 45, 3743–53.
  • Sridhar H, Jayshree RS, Bapsy PP, Appaji L, Navin Kumar M, Shafiulla M, VijayKumar BR. (2002). Invasive aspergillosis in cancer. Mycoses, 45, 358–63.
  • Staples CA, Kang EY, Wright JL, Phillips P, Muller NL. (1995). Invasive pulmonary aspergillosis in AIDS: radiographic, CT, and pathologic findings. Radiology, 196, 409–14.
  • Stevens DA. (2002). Diagnosis of fungal infections: current status. J Antimicrob Chemother, 49 Suppl 1, 11–9.
  • Swanink CM, Meis JF, Rijs AJ, Donnelly JP, Verweij PE. (1997). Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol, 35, 257–60.
  • Tasaka S, Tokuda H, Sakai F, Fujii T, Tateda K, Johkoh T, Ohmagari N, Ohta H, Araoka H, Kikuchi Y, Yasui M, Inuzuka K, Goto H. (2010). Comparison of clinical and radiological features of Pneumocystis pneumonia between malignancy cases and acquired immunodeficiency syndrome cases: a multicenter study. Intern Med, 49, 273–81.
  • Thiruchelvan N, Wuu KY, Arseculeratne SN, Ashraful-Haq J. (1998). A pseudo-cryptococcal artefact derived from leucocytes in wet India ink mounts of centrifuged cerebrospinal fluid. J Clin Pathol, 51, 246–8.
  • Thornton CR. (2008). Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis. Clin Vaccine Immunol, 15, 1095–105.
  • Tokunaga S, Ohkawa M, Takashima M, Seto C, Nakamura S. (1995). D-arabinitol versus mannan antigen and candidal protein antigen as a serum marker for Candida pyelonephritis. Eur J Clin Microbiol Infect Dis, 14, 118–21.
  • Torres-Rodriguez JM, Madrenys-Brunet N, Nolla-Salas J, Carceller A, Tur C. (1997). Candiduria in non-neutropenic critically-ill surgical patients. Detection of IgA, IgG and IgM antibodies to Candida albicans by germ tube immunofluorescence. Mycoses, 40, 439–44.
  • van Deventer AJ, van Vliet HJ, Hop WC, Goessens WH. (1994). Diagnostic value of anti-Candida enolase antibodies. J Clin Microbiol, 32, 17–23.
  • Vasquez JE, Mehta JB, Agrawal R, Sarubbi FA. (1998). Blastomycosis in northeast Tennessee. Chest, 114, 436–43.
  • Vigano EF, Vasconi E, Agrappi C, Clerici P. (2002). Use of simulated blood cultures for time to detection comparison between BacT/ALERT and BACTEC 9240 blood culture systems. Diagn Microbiol Infect Dis, 44, 235–40.
  • Viscoli C, Machetti M, Cappellano P, Bucci B, Bruzzi P, Van Lint MT, Bacigalupo A. (2004). False-positive galactomannan Platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clin Infect Dis, 38, 913–6.
  • von Eiff M, Roos N, Schulten R, Hesse M, Zuhlsdorf M, van de Loo J. (1995). Pulmonary aspergillosis: early diagnosis improves survival. Respiration, 62, 341–7.
  • Walsh TJ, Hathorn JW, Sobel JD, Merz WG, Sanchez V, Maret SM, Buckley HR, Pfaller MA, Schaufele R, Sliva C. (1991). Detection of circulating Candida enolase by immunoassay in patients with cancer and invasive candidiasis. N Engl J Med, 324, 1026–31.
  • Wang P. (2011). Rapid differentiation of Candida albicans from non-C. albicans directly in a variety of clinical specimens using fluorescent in situ hybridisation. Mycoses, in press.
  • Wang Y, Doucette S, Qian Q, Kirby JE. (2007). Yield of primary and repeat induced sputum testing for Pneumocystis jiroveci in human immunodeficiency virus-positive and -negative patients. Arch Pathol Lab Med, 131, 1582–4.
  • Warren RJ, Perceval A, Dwyer BW. (1993). Comparative evaluation of cryptococcal latex tests. Pathology, 25, 76–80.
  • Weig M, Frosch M, Tintelnot K, Haas A, Gross U, Linsmeier B, Heesemann J. (2001). Use of recombinant mitogillin for improved serodiagnosis of Aspergillus fumigatus-associated diseases. J Clin Microbiol, 39, 1721–30.
  • Weiner MH, Coats-Stephen M. (1979). Immunodiagnosis of systemic candidiasis: mannan antigenemia detected by radioimmunoassay in experimental and human infections. J Infect Dis, 140, 989–93.
  • Westh H, Lisby G, Breysse F, Boddinghaus B, Chomarat M, Gant V, Goglio A, Raglio A, Schuster H, Stuber F, Wissing H, Hoeft A. (2009). Multiplex real-time PCR and blood culture for identification of bloodstream pathogens in patients with suspected sepsis. Clin Microbiol Infect, 15, 544–51.
  • Wheat LJ. (2006). Improvements in diagnosis of histoplasmosis. Expert Opin Biol Ther, 6, 1207–21.
  • Wheat LJ. (2009). Approach to the diagnosis of the endemic mycoses. Clin Chest Med, 30, 379–89.
  • Wheat LJ, Cloud G, Johnson PC, Connolly P, Goldman M, Le Monte A, Fuller DE, Davis TE, Hafner R. (2001). Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole. Antimicrob Agents Chemother, 45, 2354–7.
  • Wheat LJ, Connolly-Stringfield P, Blair R, Connolly K, Garringer T, Katz BP. (1991). Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels. Ann Intern Med, 115, 936–41.
  • Wheat LJ, Connolly-Stringfield PA, Baker RL, Curfman MF, Eads ME, Israel KS, Norris SA, Webb DH, Zeckel ML. (1990). Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine. (Baltimore), 69, 361–74.
  • Wheat LJ, Garringer T, Brizendine E, Connolly P. (2002). Diagnosis of histoplasmosis by antigen detection based upon experience at the histoplasmosis reference laboratory. Diagn Microbiol Infect Dis, 43, 29–37.
  • White PL, Barton R, Guiver M, Linton CJ, Wilson S, Smith M, Gomez BL, Carr MJ, Kimmitt PT, Seaton S, Rajakumar K, Holyoake T, Kibbler CC, Johnson E, Hobson RP, Jones B, Barnes RA. (2006). A consensus on fungal polymerase chain reaction diagnosis?: a United Kingdom-Ireland evaluation of polymerase chain reaction methods for detection of systemic fungal infections. J Mol Diagn, 8, 376–84.
  • White PL, Bretagne S, Klingspor L, Melchers WJ, McCulloch E, Schulz B, Finnstrom N, Mengoli C, Barnes RA, Donnelly JP, Loeffler J. (2010). Aspergillus PCR: one step closer to standardization. J Clin Microbiol, 48, 1231–40.
  • Wiederhold NP, Thornton CR, Najvar LK, Kirkpatrick WR, Bocanegra R, Patterson TF. (2009). Comparison of lateral flow technology and galactomannan and. (1->3)-beta-D-glucan assays for detection of invasive pulmonary aspergillosis. Clin Vaccine Immunol, 16, 1844–6.
  • Williams B, Fojtasek M, Connolly-Stringfield P, Wheat J. (1994). Diagnosis of histoplasmosis by antigen detection during an outbreak in Indianapolis, Ind. Arch Pathol Lab Med, 118, 1205–8.
  • Wilson DA, Joyce MJ, Hall LS, Reller LB, Roberts GD, Hall GS, Alexander BD, Procop GW. (2005). Multicenter evaluation of a Candida albicans peptide nucleic acid fluorescent in situ hybridization probe for characterization of yeast isolates from blood cultures. J Clin Microbiol, 43, 2909–12.
  • Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. (2004). Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis, 39, 309–17.
  • Wong B, Brauer KL, Tsai RR, Jayasimhulu K. (1989). Increased amounts of the Aspergillus metabolite D-mannitol in tissue and serum of rats with experimental aspergillosis. J Infect Dis, 160, 95–103.
  • Xu B, Shi P, Wu H, Guo X, Wang Q, Zhou S. (2010). Utility of FDG PET/CT in guiding antifungal therapy in acute leukemia patients with chronic disseminated candidiasis. Clin Nucl Med, 35, 567–70.
  • Yeo SF, Huie S, Sofair AN, Campbell S, Durante A, Wong B. (2006). Measurement of serum D-arabinitol/creatinine ratios for initial diagnosis and for predicting outcome in an unselected, population-based sample of patients with Candida fungemia. J Clin Microbiol, 44, 3894–9.
  • Yu VL, Muder RR, Poorsattar A. (1986). Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. Am J Med, 81, 249–54.
  • Zaragoza R, Peman J, Quindos G, Iruretagoyena JR, Cuetara MS, Ramirez P, Gomez MD, Camarena JJ, Viudes A, Ponton J. (2009a). Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients. Clin Microbiol Infect, 15, 592–5.
  • Zaragoza R, Peman J, Quindos G, Iruretagoyena JR, Cuetara MS, Ramirez P, Gomez MD, Camarena JJ, Viudes A, Ponton J. (2009b). Kinetic patterns of Candida albicans germ tube antibody in critically ill patients: influence on mortality. Clin Vaccine Immunol, 16, 1527–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.